West Pharmaceutical Services
Open
$327.99
Prev. Close
$327.87
High
$328.87
Low
$327.66
Market Snapshot
$23.68B
43.6
6.75
$2.89B
West Pharmaceutical Services, Inc. engages in the manufacture and marketing of pharmaceuticals, biologics, vaccines, and consumer healthcare products. The company is headquartered in Exton, Pennsylvania and currently employs 10,800 full-time employees. The firm operates in two segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers elastomers & primary containment, drug delivery devices, integrated solutions, and analytical lab services, primarily to biologic, generic, and pharmaceutical drug customers. The Contract-Manufactured Products reportable segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. This segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
West Pharmaceutical Services continues to demonstrate strong shareholder value, reflecting its prominent position in the pharmaceutical packaging and delivery solutions industry.
West Pharmaceutical Services, Inc. engages in the manufacture and marketing of pharmaceuticals, biologics, vaccines, and consumer healthcare products. The company is headquartered in Exton, Pennsylvania and currently employs 10,800 full-time employees. The firm operates in two segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers elastomers & primary containment, drug delivery devices, integrated solutions, and analytical lab services, primarily to biologic, generic, and pharmaceutical drug customers. The Contract-Manufactured Products reportable segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. This segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
Recently from Cashu

West Pharmaceutical Services Names Michel Lagarde as New President and CEO Effective 2026
West Pharmaceutical Services has made a significant leadership change by appointing Michel Lagarde as the new President and CEO, effective August 31, 2026. This transition marks a pivotal moment for t…

West Pharmaceutical Services Appoints Michel Lagarde as New President and CEO
West Pharmaceutical Services (WST) announces a significant leadership change with the appointment of Michel Lagarde as the new President and CEO. Set to take effect on August 31, 2026, Lagarde's arriv…

West Pharmaceutical Services Appoints Michel Lagarde as New President and CEO, Driving Innovation Forward
West Pharmaceutical Services (Ticker: WST) announces a significant leadership transition, appointing Michel Lagarde as its new President and CEO, effective August 31, 2026. Lagarde succeeds Eric M. Gr…

West Pharmaceutical Services Faces Cybersecurity Incident Affecting Operations and Resilience
West Pharmaceutical Services Inc. (Ticker: WST) addresses a significant cybersecurity incident that impacts its operations and presents a challenge to its organizational resilience. The company faced…